Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Castle Biosciences, Inc. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
CSTL
Nasdaq
8071
castlebiosciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Castle Biosciences, Inc.
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
- May 13th, 2026 5:00 am
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
- May 12th, 2026 5:00 am
Castle Biosciences, Inc. Q1 2026 Earnings Call Summary
- May 6th, 2026 6:22 pm
Castle Biosciences Q1 Earnings Call Highlights
- May 6th, 2026 6:07 pm
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates
- May 6th, 2026 4:30 pm
Castle Biosciences Reports First Quarter 2026 Results
- May 6th, 2026 2:05 pm
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
- May 6th, 2026 10:06 am
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
- May 6th, 2026 10:01 am
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
- May 6th, 2026 9:57 am
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
- May 6th, 2026 9:50 am
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations
- May 6th, 2026 8:29 am
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
- May 5th, 2026 11:17 am
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus
- May 5th, 2026 10:59 am
AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales
- May 5th, 2026 10:47 am
Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know
- May 5th, 2026 7:55 am
CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates
- May 5th, 2026 6:19 am
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
- May 5th, 2026 5:00 am
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett's Esophagus
- May 4th, 2026 5:00 am
KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration
- May 1st, 2026 12:07 pm
AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum
- Apr 30th, 2026 12:32 pm
Scroll